| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3834860 | SEMERGEN - Medicina de Familia | 2013 | 8 Pages |
Abstract
The use of these drugs to control diabetic and hypertensive patients resulted in all cases being cost-effective (more effective and lower cost compared to “no treatment”). Manidipine/delapril showed the best relation cost-utility (1,970 â¬/QALY (quality-adjusted life year)) followed by amlodipine/olmesartan and amlodipine/valsartan (2,087 and 2,237 â¬/QALY, respectively).
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
A.J. GarcÃa Ruiz, J.A. Divisón Garrote, N. GarcÃa-Agua Soler, F. Morata GarcÃa de la Puerta, A.C. Montesinos Gálvez, L. Ávila Lachica,